Panchsheel Organics Limited
BSE: PANCHSHEEL
Prev Close
136.05
Open Price
133.6
Volume
5,535
Today Low / High
131 / 138.95
52 WK Low / High
126 / 223.95
Range
130 - 144
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 136.75, reflecting a change of 0.7 (0.51452%). The expected target range on the BSE is 130 - 144. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Panchsheel Organics Limited Graph
Panchsheel Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Panchsheel Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 136.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 136.75 | 138.12 | 124.31 - 151.93 |
139.49 | 111.59 - 167.38 | ||
140.85 | 98.60 - 183.11 | ||
Bearish Scenario | 136.75 | 135.38 | 121.84 - 148.92 |
134.02 | 107.21 - 160.82 | ||
132.65 | 92.85 - 172.44 |
Overview of Panchsheel Organics Limited
ISIN
INE316G01019
Industry
Medical - Pharmaceuticals
Vol.Avg
15,896
Market Cap
1,801,229,018
Last Dividend
3.2
Official Website
IPO Date
2006-06-13
DCF Diff
63.46
DCF
88
Financial Ratios Every Investor Needs
Stock Dividend of PANCHSHEEL
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2025-08-22 | August 22, 25 | 0.8 | 0.8 | 2025-08-22 | 2025-09-13 | |
2025-06-06 | June 06, 25 | 0.8 | 0.8 | 2025-06-06 | 2025-10-01 | |
2025-02-28 | February 28, 25 | 0.8 | 0.8 | 2025-02-28 | 2025-03-13 | |
2024-11-28 | November 28, 24 | 0.8 | 0.8 | 2024-11-28 | 2024-12-13 | |
2024-09-23 | September 23, 24 | 0.8 | 0.8 | 2024-09-23 | 2024-10-30 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 107.18 Cr | 69.16 Cr | 38.02 Cr | 0.3547 | 0.00 Cr | 8.15 Cr | 15.40 Cr | 13.79 Cr | 10.47 | 20.67 Cr | 0.1287 |
2024-03-31 | 105.22 Cr | 69.86 Cr | 35.36 Cr | 0.3361 | 0.00 Cr | 6.76 Cr | 18.08 Cr | 14.11 Cr | 10.71 | 21.39 Cr | 0.1341 |
2023-03-31 | 103.18 Cr | 66.68 Cr | 36.50 Cr | 0.3537 | 0.00 Cr | 0.72 Cr | 18.41 Cr | 14.07 Cr | 12.78 | 20.83 Cr | 0.1364 |
2022-03-31 | 69.02 Cr | 39.92 Cr | 29.10 Cr | 0.4216 | 0.00 Cr | 0.51 Cr | 11.60 Cr | 8.36 Cr | 8.33 | 12.70 Cr | 0.1211 |
2021-03-31 | 49.56 Cr | 28.73 Cr | 10.08 Cr | 0.2035 | 0.00 Cr | 0.38 Cr | 7.50 Cr | 5.01 Cr | 4.99 | 8.62 Cr | 0.1010 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 4.15 Cr | 163.28 Cr | 29.42 Cr | 133.8617 Cr | 5.44 Cr | 1.28 Cr | 45.90 Cr | 32.74 Cr | 0.00 Cr | 0.00 Cr | 35.72 Cr | 24.2764 Cr |
2024-03-31 | 21.85 Cr | 159.05 Cr | 34.02 Cr | 125.0346 Cr | 6.31 Cr | -15.54 Cr | 39.52 Cr | 19.38 Cr | 0.00 Cr | 0.00 Cr | 31.70 Cr | 29.4788 Cr |
2023-03-31 | 3.36 Cr | 122.68 Cr | 26.62 Cr | 96.0632 Cr | 5.58 Cr | 2.22 Cr | 32.44 Cr | 11.22 Cr | 0.00 Cr | 0.00 Cr | 31.49 Cr | 23.6824 Cr |
2022-03-31 | 1.87 Cr | 73.91 Cr | 26.50 Cr | 47.4101 Cr | 4.11 Cr | 2.24 Cr | 25.26 Cr | 8.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 22.4593 Cr |
2021-03-31 | 4.24 Cr | 57.86 Cr | 18.18 Cr | 39.6839 Cr | 3.76 Cr | -0.48 Cr | 18.79 Cr | 8.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 15.8542 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 3.8345 Cr | -16.3271 Cr | -5.2023 Cr | -11.7214 Cr | -17.6950 Cr | 4.1520 Cr | -15.5559 Cr | 18.0970 Cr | -0.8723 Cr | -3.9557 Cr | -6.3754 Cr |
2024-03-31 | 9.5697 Cr | -7.2166 Cr | 16.0295 Cr | -0.3240 Cr | 18.3826 Cr | 21.8470 Cr | -9.8937 Cr | 14.1076 Cr | 0.7295 Cr | -3.5260 Cr | -7.0801 Cr |
2023-03-31 | 0.0421 Cr | -34.3724 Cr | 35.8221 Cr | -3.9116 Cr | 1.4918 Cr | 3.4644 Cr | -3.9537 Cr | 19.0693 Cr | 1.4662 Cr | -3.5307 Cr | -7.1856 Cr |
2022-03-31 | -1.7463 Cr | -0.0201 Cr | -0.6007 Cr | -3.2770 Cr | -2.3671 Cr | 1.9726 Cr | -1.5307 Cr | 11.3983 Cr | 0.3534 Cr | -0.6652 Cr | -6.4663 Cr |
2021-03-31 | 4.8923 Cr | -0.5928 Cr | -1.4984 Cr | 3.1057 Cr | 2.8011 Cr | 4.3397 Cr | -1.7866 Cr | 7.2935 Cr | -0.8641 Cr | -0.6416 Cr | -3.3177 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 23.56 Cr | 14.93 Cr | 8.63 Cr | 0.3663 | 3.18 Cr | 2.85 Cr | 2.16 | 4.41 Cr | 0.1208 |
2025-03-31 | 27.70 Cr | 18.42 Cr | 9.28 Cr | 0.3351 | 2.98 Cr | 2.91 Cr | 2.21 | 4.17 Cr | 0.1051 |
2024-12-31 | 26.24 Cr | 16.16 Cr | 10.09 Cr | 0.3844 | 3.96 Cr | 3.67 Cr | 2.79 | 5.50 Cr | 0.1398 |
2024-09-30 | 27.18 Cr | 16.69 Cr | 10.49 Cr | 0.3858 | 4.57 Cr | 3.79 Cr | 2.88 | 5.83 Cr | 0.1393 |
2024-06-30 | 26.05 Cr | 17.89 Cr | 8.16 Cr | 0.3133 | 3.89 Cr | 3.43 Cr | 2.60 | 5.17 Cr | 0.1315 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 0.00 Cr | 0.00 Cr | 4.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -133.86 Cr |
2025-03-31 | 4.15 Cr | 0.26 Cr | 4.41 Cr | 34.98 Cr | 45.90 Cr | 88.73 Cr | 32.74 Cr | 163.28 Cr | 29.42 Cr |
2024-12-31 | 0.00 Cr | 0.00 Cr | 0.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -131.20 Cr |
2024-09-30 | 0.20 Cr | 0.31 Cr | 0.51 Cr | 56.87 Cr | 40.50 Cr | 98.98 Cr | 24.74 Cr | 169.16 Cr | 37.97 Cr |
2024-06-30 | 0.00 Cr | 0.00 Cr | 22.09 Cr | 0.00 Cr | 0.00 Cr | 22.09 Cr | 0.00 Cr | 0.00 Cr | -125.03 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 2.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2025-03-31 | 2.91 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-12-31 | 3.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-09-30 | 3.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-06-30 | 3.43 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
2021-12-06 | December 06, 21 | 2:1 |
2021-12-02 | December 02, 21 | 2:1 |
Similar Stocks: Medical - Pharmaceuticals
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
MedPlus Health Services Limited | MEDPLUS | ₹755.15 | ₹90,424,452,790.00 | ₹103,409.00 |
Key Executives
Gender: male
Year Born: 1957
Gender: male
Year Born: 1945
Gender: male
Year Born:
Gender: male
Year Born: 1955
Gender: female
Year Born:
FAQs about Panchsheel Organics Limited
The CEO is Mahendra Abhaychand Turakhia.
The current price is ₹136.75.
The range is ₹126-223.95.
The market capitalization is ₹180.12 crores.
The dividend yield is 2.34%.
The P/E ratio is 13.63.
The company operates in the Healthcare sector.
Overview of Panchsheel Organics Limited (ISIN: INE316G01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹180.12 crores and an average daily volume of 15,896 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹3.2.